Smoking is likely to increase the risk of developing severe COVID-19 and dying from the virus, according to new research...
Respiratory medicine clinician researchers have been awarded almost $15 million by the NHMRC for research projects according to its list...
Two biomarkers flag accelerated lung function decline in COPD Two biomarkers can predict people who are likely o develop COPD...
Airborne health advisor in TIME magazine’s 100 most influential people An Australian expert on air quality and health, Distinguished Professor...
Endoscopic lung volume reduction (ELVR) for advanced COPD that is refractory to standard care has been associated with significant improvements...
Patients with resected, early-stage non-small cell lung cancer (NSCLC) may benefit from adjuvant immunotherapy following adjuvant chemotherapy, according to new...
A panel of Australian and international experts present their highlights from the ERS International Congress. They also discuss the challenges...
Inhaler technology company Vectura’s shareholders have backed a £1.1 billion takeover offer from tobacco giant Philip Morris International (PMI), giving...
Children with asthma who are overweight or obese may be less likely to respond to treatment with inhaled steroids potentially...
Inhaler boycott possible after tobacco company takeover, TSANZ warns Respiratory specialists may boycott COPD inhalers that use Vectura technology if...
